Radiotherapy or radiosurgery is the primary treatment for most patients with primary brain tumors and metastatic tumors of the brain and spine. With increasing overall survival for these patients, they are at an increasing risk of tumor recurrence within a previously irradiated field.

Improvement in cancer therapies have increased the number of long-term survivors with brain and spine tumors. While radiation therapy remains one of the cornerstones of treatment modalities, it is associated with toxicities that can impact quality of life.

This activity begins with discussion on optimal ways to identify high risk patients, approaches to patient education for all women, with a specific focus on those women disproportionately affected by BCRL/UED, and clinical workflows for high risk patients/those who have already developed BCRL/UED

Significant advances in systemic treatment options have positively impacted breast cancer survivorship.